See more : C Cheng Holdings Limited (1486.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Grand Brilliance Group Holdings Limited (8372.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Grand Brilliance Group Holdings Limited, a leading company in the Medical – Distribution industry within the Healthcare sector.
- American Future Fuel Corporation (AMPS.CN) Income Statement Analysis – Financial Results
- Chongqing Rural Commercial Bank Co., Ltd. (CRCBY) Income Statement Analysis – Financial Results
- Anhui Quanchai Engine Co., Ltd. (600218.SS) Income Statement Analysis – Financial Results
- Chengdu Xgimi Technology Co.,Ltd. (688696.SS) Income Statement Analysis – Financial Results
- The PNC Financial Services Group, Inc. (PNC) Income Statement Analysis – Financial Results
Grand Brilliance Group Holdings Limited (8372.HK)
About Grand Brilliance Group Holdings Limited
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 81.90M | 76.70M | 71.98M | 70.24M | 67.23M | 58.05M | 53.70M | 51.66M | 52.88M |
| Cost of Revenue | 39.96M | 37.19M | 35.63M | 36.63M | 30.85M | 26.58M | 23.78M | 25.63M | 24.69M |
| Gross Profit | 41.94M | 39.51M | 36.35M | 33.62M | 36.37M | 31.46M | 29.93M | 26.03M | 28.19M |
| Gross Profit Ratio | 51.21% | 51.51% | 50.50% | 47.86% | 54.11% | 54.20% | 55.73% | 50.38% | 53.31% |
| Research & Development | 4.08M | 2.48M | 2.07M | 583.00K | 406.00K | 554.00K | 499.00K | 541.00K | 478.00K |
| General & Administrative | 35.35M | 30.47M | 29.23M | 25.37M | 24.39M | 22.71M | 29.82M | 11.28M | 12.31M |
| Selling & Marketing | 1.32M | 1.21M | 1.20M | 899.00K | 935.00K | 1.02M | 841.00K | 795.00K | 800.00K |
| SG&A | 36.67M | 31.68M | 30.43M | 26.27M | 25.32M | 23.73M | 30.67M | 12.07M | 13.11M |
| Other Expenses | 0.00 | 417.00K | -321.00K | 114.00K | 50.00K | -106.00K | 240.00K | 162.00K | 344.00K |
| Operating Expenses | 41.94M | 30.66M | 30.43M | 24.62M | 25.29M | 23.68M | 30.62M | 12.00M | 13.00M |
| Cost & Expenses | 76.43M | 67.85M | 66.06M | 61.25M | 56.15M | 50.26M | 54.39M | 37.63M | 37.68M |
| Interest Income | 1.66M | 438.00K | 11.00K | 357.00K | 840.00K | 565.00K | 3.00K | 0.00 | 0.00 |
| Interest Expense | 106.00K | 152.00K | 140.00K | 109.00K | 68.00K | 0.00 | 0.00 | 0.00 | 7.00K |
| Depreciation & Amortization | 4.62M | 4.37M | 4.25M | 3.44M | 2.82M | 928.00K | 400.00K | 453.00K | 482.00K |
| EBITDA | 13.20M | 14.09M | 9.87M | 12.91M | 14.79M | 9.17M | -47.00K | 14.41M | 16.02M |
| EBITDA Ratio | 16.11% | 12.42% | 13.71% | 18.37% | 22.00% | 15.01% | -0.53% | 28.35% | 30.30% |
| Operating Income | 5.25M | 7.83M | 5.92M | 7.35M | 11.05M | 7.74M | -687.00K | 14.03M | 15.19M |
| Operating Income Ratio | 6.41% | 10.21% | 8.22% | 10.46% | 16.44% | 13.33% | -1.28% | 27.16% | 28.73% |
| Total Other Income/Expenses | 2.96M | 1.47M | -440.00K | 2.01M | 822.00K | 243.00K | 240.00K | 162.00K | 337.00K |
| Income Before Tax | 8.21M | 9.38M | 5.48M | 9.36M | 11.90M | 8.25M | -447.00K | 14.19M | 15.53M |
| Income Before Tax Ratio | 10.02% | 12.23% | 7.61% | 13.32% | 17.71% | 14.21% | -0.83% | 27.47% | 29.37% |
| Income Tax Expense | 420.00K | 1.82M | 1.43M | 1.50M | 2.34M | 1.64M | 2.63M | 2.39M | 2.55M |
| Net Income | 7.86M | 7.56M | 4.05M | 7.86M | 9.57M | 6.61M | -3.08M | 11.80M | 12.98M |
| Net Income Ratio | 9.59% | 9.86% | 5.62% | 11.19% | 14.23% | 11.38% | -5.74% | 22.85% | 24.55% |
| EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 |
| EPS Diluted | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 |
| Weighted Avg Shares Out | 800.00M | 800.00M | 800.00M | 800.00M | 800.00M | 800.00M | 633.38M | 800.00M | 800.00M |
| Weighted Avg Shares Out (Dil) | 800.00M | 800.00M | 800.00M | 800.00M | 800.00M | 800.00M | 633.38M | 800.00M | 800.00M |
Source: https://incomestatements.info
Category: Stock Reports